Investors & Media Financials & Filings Investor Relations Overview Corporate Governance Press Releases & Statements Events & Presentations SEC Filings Annuals and Proxies Investor FAQs Financials & Filings Quarterly Results Stock Information Analyst Coverage Email Alerts Subscription Notice of Pendency of Settlement of Action Financials & Filings Show all 2023 Fourth Quarter Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress Form 10-K Annual Reports Title View 2021 Annual Report 2021 Annual Report 1.8 MB 2020 Annual Report 2020 Annual Report 2.6 MB Proxy Statements Title View 2023 Proxy Statement 2023 Proxy Statement 2.7 MB Form 10-K Filing date View Apr 27, 2023 View HTML 0001193125-23-122166.pdf Form 10-Q Filing date View Nov 7, 2023 0000950170-23-059750.pdf 0000950170-23-059750.rtf 0000950170-23-059750.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML Aug 7, 2023 0000950170-23-038739.pdf 0000950170-23-038739.rtf 0000950170-23-038739.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
Financials & Filings Show all 2023 Fourth Quarter Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress Form 10-K Annual Reports Title View 2021 Annual Report 2021 Annual Report 1.8 MB 2020 Annual Report 2020 Annual Report 2.6 MB Proxy Statements Title View 2023 Proxy Statement 2023 Proxy Statement 2.7 MB Form 10-K Filing date View Apr 27, 2023 View HTML 0001193125-23-122166.pdf Form 10-Q Filing date View Nov 7, 2023 0000950170-23-059750.pdf 0000950170-23-059750.rtf 0000950170-23-059750.xls EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT View HTML Aug 7, 2023 0000950170-23-038739.pdf 0000950170-23-038739.rtf 0000950170-23-038739.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
